Relapsed Follicular Lymphoma
9 clinical trials · Condition
◉ Watch Relapsed Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187) | H. Lee Moffitt Cancer Center and Research Institute | 2019-12-06 |
| Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL (NCT03806179) | Nordic Nanovector | 2018-10-04 |
| Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma (NCT02956382) | Georgetown University | 2017-03-01 |
| Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma (NCT00715208) | Millennium Pharmaceuticals, Inc. | 2008-09-01 |
Track Relapsed Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.